ae0047 has been researched along with dihydropyridines in 23 studies
| Studies (ae0047) | Trials (ae0047) | Recent Studies (post-2010) (ae0047) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 23 | 0 | 1 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (82.61) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishikawa, M; Okamura, T; Toda, N; Yoshida, K | 1 |
| Ashimori, A; Fukaya, C; Kagitani, M; Ohe, K; Ohtaki, Y; Tanaka, M; Uchida, T; Watanabe, M; Yokoyama, K | 1 |
| Kido, H; Nakamura, F; Sugimoto, T; Uchida, Y | 1 |
| Nishikawa, M; Okamura, T; Toda, N | 1 |
| Kagitani, Y; Kawamura, T; Nagai, H; Narita, Y; Shinyama, H; Uchida, T; Watanabe, M | 1 |
| Hashimoto, T; Katsura, M; Kuriyama, K | 1 |
| Hayashi, K; Kido, H; Shinyama, H; Uchida, T; Watanabe, M | 1 |
| Ebisu, H; Egi, Y; Fujino, Y; Hayashi, K; Inoue, S; Kido, H; Kubo, Y; Nakamura, N; Nishikawa, M; Ohtaki, Y; Uchida, T; Yamanaga, K | 1 |
| Ebisu, H; Egi, Y; Hayashi, K; Kido, H; Kubo, Y; Nakamura, N; Nishikawa, M; Shinyama, H | 1 |
| Gohda, M; Hayashi, K; Kido, H; Kubo, Y; Matzno, S; Nakamura, N; Yamauchi, T | 1 |
| Egi, Y; Iwamoto, M; Kagitani, Y; Kawabata, Y; Kawamura, T; Nakamura, N; Shinyama, H; Tanaka, H | 1 |
| Hayashi, K; Kagitani, Y; Kawamura, T; Nakamura, N; Shinyama, H | 1 |
| Egi, Y; Hayashi, K; Iwamoto, M; Kagitani, Y; Kido, H; Koyama, M; Kubo, Y; Nakamura, N; Shinyama, H | 1 |
| Akira, T; Iwamoto, M; Kagitani, Y; Nakamura, N; Shinyama, H; Uchida, T; Yamanaga, K | 1 |
| Kagitani, Y; Kawamura, T; Nagai, H; Nakamura, N; Narita, Y; Shinyama, H | 2 |
| Hayashi, K; Imada, T; Kagitani, Y; Kido, H; Matzno, S; Nakamura, N; Shinyama, H; Yamauchi, T | 1 |
| Gohda, M; Kido, H; Matzno, S; Nakamura, N; Nishikawa, M; Shinyama, H; Yamanaga, K | 1 |
| Kido, H; Kubo, Y; Nakamura, N; Nakayama, T; Nishikawa, M | 1 |
| Hayashi, K; Matsumura, Y; Ohmagari, M; Tamai, I; Yamasaki, T | 1 |
| Hayashi, K; Matsumura, Y | 1 |
| AbouChehade, JE; Bakri, SJ; Dalvin, LA; Damento, GM; Garcia, MD; Hodge, DO; Iezzi, R; Meissner, I; Shah, SM; Starr, MR | 1 |
2 review(s) available for ae0047 and dihydropyridines
| Article | Year |
|---|---|
Vatanidipine hydrochloride: a new long-lasting antihypertensive agent.
Topics: Animals; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Humans; Hypertension; Nitrendipine | 2001 |
Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Humans; Hyperlipidemias; Hypertension; Memory Disorders; Myocardial Ischemia; Rats | 2002 |
21 other study(ies) available for ae0047 and dihydropyridines
| Article | Year |
|---|---|
AE0047, a new dihydropyridine Ca2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries.
Topics: Adrenergic alpha-Agonists; Animals; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Mesenteric Arteries; Nicardipine; Substance P; Sympathetic Nervous System; Tritium; Vasodilation | 1992 |
Synthesis and pharmacological effects of optically active 2-[4-(4-benzhydryl-1-piperazinyl)phenyl]-ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride.
Topics: Animals; Antihypertensive Agents; Dihydropyridines; Male; Rats; Rats, Inbred SHR; Stereoisomerism | 1991 |
[Angiographic studies on the effects of a novel calcium antagonist AE0047 on cerebral arteries in dogs, with special reference to the preventive effects of AE0047 on cerebral vasoconstriction induced by endothelin].
Topics: Animals; Calcium Channel Blockers; Cerebral Arteries; Cerebrovascular Circulation; Dihydropyridines; Dogs; Endothelins; Female; Ischemic Attack, Transient; Male; Peptides; Vasoconstriction; Vasodilator Agents | 1990 |
[Effect of the novel calcium antagonist AE0047 on responses of isolated dog blood vessels to vasoconstricting agents and to nerve stimulation].
Topics: Animals; Blood Vessels; Calcium Channel Blockers; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Neurotransmitter Agents; Nicotine; Peripheral Nerves; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Hemodynamics; Hypertension; Male; Rats; Rats, Inbred SHR | 1995 |
[Effects of AE0047, a novel Ca antagonist, on monoamine, acetylcholine and neuroactive amino acids contents in rat brain].
Topics: Acetylcholine; Amino Acids; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Calcium Channel Blockers; Dihydropyridines; Male; Rats; Rats, Wistar; Serotonin; Tryptophan Hydroxylase | 1994 |
Effects of AE0047 on renal haemodynamics and function in anaesthetized dogs.
Topics: Anesthesia; Animals; Calcium Channel Blockers; Dihydropyridines; Diuresis; Dogs; Hemodynamics; Infusions, Intra-Arterial; Injections, Intravenous; Kidney; Natriuresis; Nicardipine; Renal Artery | 1993 |
[Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Desoxycorticosterone; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Hypertension, Renal; Injections, Intravenous; Nicardipine; Nitrendipine; Rats; Rats, Inbred SHR | 1997 |
[Antihypertensive effects of long-term treatment with AE0047, a novel long-lasting calcium antagonist, in hypertensive models of rats and dogs].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Dihydropyridines; Dogs; Heart Rate; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred SHR | 1997 |
Possible mechanism of action of AE0047, a calcium antagonist, on triglyceride metabolism.
Topics: Animals; Apolipoproteins B; Calcium Channel Blockers; Cell Line; Dihydropyridines; Fatty Acids, Nonesterified; Female; Lipoprotein Lipase; Liver; Rats; Rats, Zucker; Triglycerides | 1997 |
Effects of the calcium antagonist AE0047 on the development of neurological deficit and infarction after middle cerebral artery occlusion in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Brain; Calcium Channel Blockers; Cerebral Infarction; Dihydropyridines; Heart Rate; Intracranial Embolism and Thrombosis; Male; Nervous System Diseases; Rats; Rats, Inbred SHR | 1997 |
Effects of AE0047 on cerebral ischaemia and oedema after middle cerebral artery occlusion in cats.
Topics: Animals; Blood Pressure; Body Water; Brain Ischemia; Calcium Channel Blockers; Cats; Cerebral Arteries; Cerebral Cortex; Dihydropyridines; Male; Regional Blood Flow | 1997 |
Preventative and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Hypertension; Kidney Diseases; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1997 |
AE0047-mediated calcium channel blocking in vascular smooth muscles.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Calcium Radioisotopes; Cattle; Chemical Phenomena; Chemistry, Physical; Dihydropyridines; Dogs; Drug Carriers; In Vitro Techniques; Isradipine; Liposomes; Male; Membranes; Microsomes; Muscle Contraction; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Rats, Wistar; Synaptic Membranes | 1997 |
Effects of long-term treatment with the calcium antagonist AE0047 on cerebrovascular autoregulation and hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cerebral Arteries; Cerebrovascular Circulation; Dihydropyridines; Disease Models, Animal; Homeostasis; Hypertension; Hypertrophy; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1997 |
Possible mechanism for the anti-atherosclerotic action of the calcium channel blocker AE0047 in cholesterol-fed rabbits.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Body Weight; Calcium; Calcium Channel Blockers; Cholesterol, Dietary; Diet; Diet, Atherogenic; Dihydropyridines; Lipids; Lipoproteins, LDL; Male; Oxidation-Reduction; Rabbits | 1998 |
Therapeutic effects of AE0047, a novel calcium antagonist, on progression of brain damage after stroke in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Brain; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Hydralazine; Male; Nicardipine; Rats; Rats, Inbred SHR; Vasodilator Agents | 1998 |
Calcium channel blocking and vasodilating actions of the novel dihydropyridine derivative AE0047.
Topics: Animals; Antihypertensive Agents; Aorta; Binding Sites; Binding, Competitive; Calcium; Calcium Channel Blockers; Cattle; Dihydropyridines; Dose-Response Relationship, Drug; Guinea Pigs; Heart Ventricles; Nicardipine; Nitrendipine; Patch-Clamp Techniques; Rats; Structure-Activity Relationship; Vasodilator Agents | 1998 |
Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Endothelium, Vascular; Heart Rate; Hypertension; Male; Prostaglandins; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Vasodilation | 1999 |
Inhibitory effects of AE0047, a new dihydropyridine Ca(2+) channel blocker, on renal nerve stimulation-induced renal actions in anesthetized dogs.
Topics: Anesthesia; Animals; Calcium Channel Blockers; Dihydropyridines; Dogs; Electric Stimulation; Female; Infusions, Intra-Arterial; Kidney; Male; Nicardipine; Renal Circulation | 2000 |
Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor.
Topics: Aged; Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Dihydropyridines; Female; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Diseases; Retrospective Studies; Stroke; Vascular Endothelial Growth Factor A | 2019 |